.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Cantor Fitzgerald
Moodys
McKinsey
Daiichi Sankyo
Citi
Colorcon
US Army
Fuji

Generated: December 16, 2017

DrugPatentWatch Database Preview

ERYTHROCIN Drug Profile

« Back to Dashboard

Which patents cover Erythrocin, and what generic alternatives are available?

Erythrocin is a drug marketed by Abbott, Hospira, and Arbor Pharms Llc. and is included in five NDAs.

The generic ingredient in ERYTHROCIN is erythromycin stearate. There are ninety-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Drug patent expirations by year for ERYTHROCIN

Pharmacology for ERYTHROCIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AbbottERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION062586-002Jan 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION050182-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION050182-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION050609-001Sep 24, 1986APRXYesYes► Subscribe► Subscribe► Subscribe
AbbottERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION062586-001Jan 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION062638-002Oct 31, 1986RXNoYes► Subscribe► Subscribe► Subscribe
HospiraERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION062638-001Oct 31, 1986APRXNoNo► Subscribe► Subscribe► Subscribe
HospiraERYTHROCINerythromycin lactobionateINJECTABLE;INJECTION050609-002Sep 24, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms LlcERYTHROCIN STEARATEerythromycin stearateTABLET;ORAL060359-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Arbor Pharms LlcERYTHROCIN STEARATEerythromycin stearateTABLET;ORAL060359-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Citi
Harvard Business School
AstraZeneca
Medtronic
Merck
UBS
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot